Recently merged CROs Accelovance and Linical rebrand, name new CEO

By Melissa Fassbender contact

- Last updated on GMT

(Image: Getty/tomertu)
(Image: Getty/tomertu)

Related tags: CRO, Accelovance, Linical, Contract research, Contract research organization, Clinical trial

Accelovance and Linical merged in March of this year to create a global midsized CRO for which ‘future possibilities are endless,’ says newly appointed CEO.

The firms merged​ with the goal to create a midsized global contract research organization (CRO) in response to the need for large-scale multinational clinical trials.

Now, the companies have announced that the CRO will operate as Linical Accelovance Group moving forward, led by its new CEO, Vita M. Lanoce, MS. Lanoce was previously the chief operating officer of Accelovance, and has worked at other companies including Covance, Synexus, and Bristol-Myers Squibb.

“I look forward to capitalizing on the talented staff of the Linical Accelovance Group, the extended geographical reach, efficiency of operations and broadening of services the merger has provided,” ​she told us.

According to Lanoce, pharma and biotech sponsors come to the CRO seeking “personal service, flexibility, operational, scientific and medical expertise, and innovative solutions they are not able to get from the mega CROs.”

“Our clients appreciate the personal, hands-on approach of our operations team along with the knowledge that each study will have an executive sponsor to support them, whether the study is a single POC study or a large multi-study clinical development program,”​ she added.

Lanoce said the company plans to continue focusing on early oncology research, while expanding its solutions into additional therapeutic areas.

“The future possibilities for this organization are endless,”​ she said, “including the potential for additional expansion in North and South America as well as Australia, while continuing to enhance our reach in China and APAC.”

Related news

Show more

Related products

show more

What should a clinical metadata repository do?

What should a clinical metadata repository do?

Formedix | 26-Jul-2021 | Technical / White Paper

Choosing a clinical metadata repository (MDR) software can be a tough task as the capabilities and features of your chosen MDR could make or break your...

Adapting supply chains to new ways of working

Adapting supply chains to new ways of working

World Courier | 15-Jul-2021 | Technical / White Paper

COVID-19 has changed the way we operate. We have adapted our supply chain solutions to meet our clients’ requirements while following World Courier standard...

Empowering Clinical Trial Sponsors with Analytics

Empowering Clinical Trial Sponsors with Analytics

PerkinElmer | 14-Jul-2021 | Technical / White Paper

Is your Clinical Data Review creating problems or solving them? Take Control of Your Data. PerkinElmer Informatics Clinical Solutions, powered by Tibco...

What are the building blocks of DCTs?

What are the building blocks of DCTs?

Medable | 26-Apr-2021 | Technical / White Paper

How to create a seamless experience across eConsent, eCOA and more.

Over the past year, tremendous progress was made toward digitizing and...

Related suppliers

Follow us


View more